StreetAlpha.app
Home › Stocks › CYPH

Cypherpunk Technologies Inc. (CYPH)

Healthcare
$1.41
▼ −18.02%
LAST CLOSE · NOV 20

Cypherpunk Technologies is a privacy technology company focused on the Zcash network, and it is also developing cancer therapies. It last closed at $1.41 on Nov 20, down 18.02% on the day. The next earnings report for CYPH is expected around Mon, Mar 15, 2027, after the close. For the quarter ended Sep 2026, CYPH reported EPS of $1.13 on revenue of $9.9M. Over its last 8 reports the stock moved an average of 11.7% the session after earnings. Over the last 12 months CYPH insiders bought $0 of stock on the open market and sold $932K, according to SEC Form 4 filings.

AI Auto Pilots
Is CYPH in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold CYPH.

Key Stats

Last 12 months
Results
Net income
$308.4M
EPS (diluted)
$2.09
Valuation
Market cap
$210.1M
149.0M shares
P/E
0.7
Price over 12 month EPS
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$56.0M
At Sep 30
Shareholder equity
$535.6M
Shares outstanding
149.0M
At Nov 12
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: −$40.6M−$40.6MFY2021FY2022: −$54.6M−$54.6MFY2022FY2023: −$81.4M−$81.4MFY2023FY2024: −$67.6M−$67.6MFY2024FY2025: $4.8M$4.8MFY2025

From CYPH's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 16). Last 12 months adds up the four latest quarters.

Next report
Mar 15
Estimated date · After the close
Reported EPS
$1.13
Quarter ended Sep 2026
Year ago EPS
-$0.08
Same quarter last year
Revenue
$9.9M
Last reported quarter
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$0.37Dec '24Mar 2025: -$0.37Mar '25Jun 2025: -$0.40Jun '25Sep 2025: -$0.08Sep '25Dec 2025: $0.92Dec '25Mar 2026: -$0.46Mar '26Jun 2026: $0.18Jun '26Sep 2026: $1.13Sep '26Latest $1.13
Revenue by quarter
Not enough quarters on file yet.
How CYPH moved after its last 8 reports
Average move the session after a report ±11.7%
Nov 16, 2026Time not announced+2.9%
Aug 12, 2026Time not announced−3.3%
May 14, 2026Time not announced+15.4%
Mar 16, 2026After the close+12.6%
Aug 14, 2025Time not announced−28.1%
May 13, 2025Time not announced+6.6%
Mar 26, 2025Time not announced+16.9%
Nov 13, 2024Time not announced−7.7%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on CYPHStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on CYPH
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on CYPH

Technical Analysis

CYPH · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend, nearing oversold

The stock is 69% below its 20 day and 99% below its 50 day average. It is 2% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 33), near oversold. The nearest support is the 200 day average at $1.38, and the nearest resistance the Pivot at $1.48.

Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityHigh, 26.7%/day
Key levels
$4.1952 week high+197.2%
$2.8050 day average+98.6%
$2.3820 day average+68.8%
$2.05Swing high (Aug 27)+45.4%
$1.94100 day average+37.6%
$1.59Pivot R1+12.8%
$1.48Pivot+5.0%
$1.41Last close
$1.38200 day average−2.1%
$1.30Pivot S1−7.8%
$1.03Swing low (May 28)−27.0%
$0.4952 week low−65.2%
Indicators
RSI (14)33.02Weak, oversold below 30Neutral
MACD-0.32Below its signal lineBearish
Stochastic3.9Near the bottom of its rangeOversold
ADX (14)17.1No clear trend
Williams %R-97.6Oversold below −80, overbought above −20Oversold
CCI (20)-131.4Oversold below −100, overbought above 100Oversold
Rate of change−51.0%Change over 10 sessionsBearish
ATR (14)$0.38Typical daily range, 26.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
What happened before, for CYPH

What happened before

See how CYPH did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow CYPH usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How CYPH has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2023.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for CYPHHow many large options trades hit CYPH, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

CYPH Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bullish
Strongly bearishNeutralStrongly bullish
  • ▲55 buying vs 19 selling
  • ▲Held by funds +4.2 pts
  • ▲Funds holding +31
  • ▲Superinvestors: 2 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding7847+66.0%
In funds' top 1000–
Held by funds14.0%9.8%+4.2 pts
New / increased38 / 1713 / 16+89.7%
Reduced / sold out11 / 86 / 5+72.7%
Put/call ratio17.930.00–
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See CYPH institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

CYPH Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$932K4 sales · 4 insiders
2026-03 sold $43K2026-08 sold $34K2026-09 sold $855KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Sep 25Khing Djien OeiDirectorSale168,750$3.92$662K
Sep 23Patricia A. MartinDirectorSale50,000$3.86$193K
Aug 26Thomas John DietzDirectorSale20,000$1.72$34K
Mar 26Christopher MirabelliDirectorSale60,000$0.71$43K
Nov 17, 2025Douglas E OnsiCEO,CFO,Pres.,GC,Treas.&Sec.Sale676,319$3.14$2.1M
Nov 17, 2025James H CavanaughDirectorSale261,840$3.14$822K
Every insider buy and sale for CYPH over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See CYPH insider trades →

From SEC Form 4 filings by CYPH's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CYPH is in one of them and how their past CYPH trades turned out.

CYPH in the AI portfolios
Loading…

CYPH News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered CYPH in an article yet. Here's the latest on the wider market.

CYPH in the news

About Cypherpunk Technologies

Cypherpunk Technologies is a privacy technology company based in Cambridge, Massachusetts. Its main focus is the Zcash network, a digital currency that allows fully shielded transactions, where the sender, recipient and amount stay hidden. It also holds ZEC, the network's coin, as part of a digital asset treasury strategy. The company has a biotechnology business that is developing cancer therapies, with its lead program in clinical stage development.

Headquarters
Cambridge, MA